Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Parstatin, a novel protease-activated receptor 1-derived inhibitor of angiogenesis.

Duncan MB, Kalluri R.

Mol Interv. 2009 Aug;9(4):168-70. doi: 10.1124/mi.9.4.4.

2.

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.

Shinkaruk S, Bayle M, Laïn G, Déléris G.

Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. Review.

PMID:
12678905
3.

Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.

Gacche RN, Meshram RJ.

Prog Biophys Mol Biol. 2013 Nov;113(2):333-54. doi: 10.1016/j.pbiomolbio.2013.10.001. Epub 2013 Oct 15. Review.

PMID:
24139944
4.

Protein C and its inhibitor in malignancy.

Suzuki K, Hayashi T.

Semin Thromb Hemost. 2007 Oct;33(7):667-72. Review.

PMID:
18000793
5.

Antiangiogenic property of human thrombin.

Chan B, Merchan JR, Kale S, Sukhatme VP.

Microvasc Res. 2003 Jul;66(1):1-14. Review.

PMID:
12826069
6.

Regulation of blood vessels by prolactin and vasoinhibins.

Clapp C, Thebault S, Macotela Y, Moreno-Carranza B, Triebel J, Martínez de la Escalera G.

Adv Exp Med Biol. 2015;846:83-95. doi: 10.1007/978-3-319-12114-7_4. Review. Erratum in: Adv Exp Med Biol. 2015;846:E1-2.

PMID:
25472535

Supplemental Content

Support Center